Slide Background
Slide Background

Our Leaders

CapnoPharm brings together an international team of leading clinicians, scientists and business professionals all focused on the same goal: to help people by offering therapeutic solutions to unmet medical needs in oncology.

Dr. Marc Reymond

Prof. Reymond, MD, is a board-certified gastrointestinal surgeon and the inventor of Pressurized IntraPeritoneal Chemotherapy (PIPAC).

He graduated as a physician from the University of Geneva, Switzerland,  completed an MBA in Science & Technology with LaSalle University, PA, USA, and a postgraduate diploma in artificial intelligence with McCombs at U Austin, TX, USA. Prof. Reymond is ranked as Top-Physician nationwide in Germany.
He has published over 180 peer-reviewed publications, 6 books, and 50+ book chapters.
He has raised more than €28 Mio R&D funding.
He is the founder of three biotechnology companies, of a non-profit biobank, and holder of nine innovation awards. He is Committee President/Member in major grant and audit agencies. He has been invited to numerous
national and international postgraduate courses and lectures in leading universities worldwide.

Stéphane Rohan Laurent

VP – Global Sales & Business Development

Stéphane has over 14 years’ experience in international sales & business development in senior corporate and consulting roles in both

Europe and Asia. Most recently, and prior to joining CapnoPharm, Stéphane was CapnoMed’s Country Head – India since 2017, before taking on the role of Regional Head – Asia & Middle East in 2020. A board-certified medical affairs specialist (BCMAS), Stéphane’s dedication to promoting innovation in cancer care is driven by his strong interpersonal skills, extensive international sales and distribution experience and ability to work effectively and creatively across cultures and geographies. Stéphane holds a Master’s degree in International Business and Economic Policy from Sciences Po Paris and a Master’s in English Language, Literature & Civilization from the Sorbonne University, Paris, France.

Dr. Ranjita Shegokar Sahoo

Heads the Pharma Business Unit at CapnoPharm. She is a well- known pharma expert specializing in a wide array of drug delivery technologies.

She finished her PhD followed by postdoctoral research in Berlin, Germany in pharmaceutical nanotechnology. Since the last 10 years, she has been active in the pharma industry in various leading roles and worked with multinational German companies such as Symrise AG, DFE Pharma GmbH & Co. KG, and PharmaSol GmbH on  innovative formulation concepts.  She is a listed inventor on more than 35+ patent applications, Editor of trending pharma books, author of 120+ publications and receiver of multiple awards.

Book Link:
Emerging Nanotechnologies in Immunology Ranjita Shegokar